HCW Biologics is trading 8.70% down at $2.10 as the broader biotech sector reverses its prior-session rally.
- XBI is down 2.47%, while the S&P 500, Nasdaq Composite, and Dow Jones are also lower as rising Treasury yields pressure risk assets.
- A company-specific lock-up covering 581,047 shares, warrants, and options ends on August 20, 2026, potentially adding supply overhang.
- No new company announcement was found.